✦ LIBER ✦

PCV52 Urapidil in Treatment of Hypertension Urgencies in the Russian Federation: Cost-Effectiveness Analysis

✍ Scribed by A. Kulikov; M. Protsenko; B. Misikova

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV17 Cost-Effectiveness Analysis of Bos

✍ V. Omelyanovsky; M. Avxentyeva; I. Krysanov; S. Goryaynov; O. Ivakhnenko; F.M. T 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV34 A COST-EFFECTIVENESS ANALYSIS OF O

✍ M Lamotte; L Annemans; R Van Loy; W Koch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PCV21 COST-EFFECTIVENESS OF HYPERTENSION

✍ J Kyriopoulos; K Athanasakis; A Zavras; A Angeli; M Geitona 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

PCV36 COST-EFFECTIVENESS AND COST-UTILIT

✍ P Kawalec; J Lis; M Glasek 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

PCV22 COST EFFECTIVENESS ANALYSIS OF BOS

✍ TJ Lee; J Kim; HS Sohn; D Kim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Cost effectiveness analysis of tuberculo

📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 60 KB